Enschede, Netherlands

Tom Beugeling

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1989.


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Tom Beugeling

Introduction

Tom Beugeling is a notable inventor based in Enschede, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the isolation of coagulation factors from blood plasma. His work has implications for medical treatments and advancements in blood-related therapies.

Latest Patents

Tom Beugeling holds a patent for a process for isolating coagulation factors, including FVIII and vWF, from blood plasma and plasma products through liquid chromatography. The patent describes an absorbent material that consists of a polymeric carrier with amino groups linked as ligands through spacers. These spacers have a chain length of at least six atoms and include at least one hydrophilic link within the chain. The ligands are designed to enhance the efficiency of isolating crucial coagulation factors, which are vital for various medical applications. He has 1 patent to his name.

Career Highlights

Throughout his career, Tom Beugeling has focused on innovative solutions in the field of biotechnology. His work has been instrumental in developing methods that improve the extraction and purification of essential proteins from biological materials. This has opened new avenues for research and therapeutic applications.

Collaborations

Tom has collaborated with several professionals in his field, including Adriaan Bantjes and Waander Riethorst. These collaborations have contributed to the advancement of his research and the successful development of his patented processes.

Conclusion

Tom Beugeling's innovative work in isolating coagulation factors showcases his commitment to advancing biotechnology. His contributions have the potential to significantly impact medical treatments and improve patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…